Orthofix Stock Based Compensation vs Begin Period Cash Flow Analysis

OFIX Stock

USD 18.91 0.23 1.23%

Orthofix Medical financial indicator trend analysis is much more than just breaking down Orthofix Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Orthofix Medical is a good investment. Please check the relationship between Orthofix Medical Stock Based Compensation and its Begin Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Stock Based Compensation vs Begin Period Cash Flow

Stock Based Compensation vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Orthofix Medical Stock Based Compensation account and Begin Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Orthofix Medical's Stock Based Compensation and Begin Period Cash Flow is 0.45. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Orthofix Medical, assuming nothing else is changed. The correlation between historical values of Orthofix Medical's Stock Based Compensation and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Orthofix Medical are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Stock Based Compensation i.e., Orthofix Medical's Stock Based Compensation and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.45

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Orthofix Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Orthofix Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.At this time, Orthofix Medical's Issuance Of Capital Stock is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.25 in 2024, whereas Selling General Administrative is likely to drop slightly above 87.6 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	349.6M	337.2M	486.3M	259.2M
Total Revenue	464.5M	460.7M	746.6M	784.0M

Gross Profit Total Revenue

Orthofix Medical fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Common Stock Shares Outstanding		0.92	0.47	0.83	0.78	0.95	0.99	0.51	-0.78	0.98	-0.03	0.95	0.16	-0.03	0.32	0.51	0.98	0.12	0.99	0.5	0.87	0.46	0.17	0.86	0.69	0.73
Total Assets	0.92		0.69	0.83	0.94	0.95	0.92	0.66	-0.58	0.92	0.03	0.97	0.14	0.03	0.62	0.75	0.94	0.43	0.9	0.75	0.76	0.69	0.45	0.84	0.74	0.68
Short Long Term Debt Total	0.47	0.69		0.34	0.83	0.45	0.49	0.91	-0.32	0.48	-0.27	0.64	0.19	-0.27	0.75	0.95	0.53	0.85	0.44	0.92	0.36	0.64	0.91	0.48	0.35	0.46
Other Current Liab	0.83	0.83	0.34		0.77	0.86	0.81	0.2	-0.48	0.77	0.4	0.85	0.26	0.4	0.29	0.43	0.78	0.13	0.8	0.51	0.64	0.5	0.09	0.73	0.75	0.6
Total Current Liabilities	0.78	0.94	0.83	0.77		0.8	0.79	0.72	-0.5	0.78	0.09	0.9	0.29	0.09	0.66	0.85	0.81	0.61	0.76	0.87	0.66	0.68	0.68	0.76	0.64	0.58
Total Stockholder Equity	0.95	0.95	0.45	0.86	0.8		0.94	0.44	-0.58	0.94	0.09	0.92	0.02	0.09	0.49	0.53	0.95	0.2	0.94	0.55	0.79	0.63	0.17	0.81	0.8	0.71
Property Plant And Equipment Net	0.99	0.92	0.49	0.81	0.79	0.94		0.53	-0.8	0.98	-0.03	0.96	0.19	-0.03	0.31	0.54	0.98	0.12	0.99	0.52	0.87	0.45	0.21	0.88	0.67	0.73
Net Debt	0.51	0.66	0.91	0.2	0.72	0.44	0.53		-0.43	0.54	-0.57	0.61	0.07	-0.57	0.65	0.84	0.58	0.7	0.49	0.74	0.43	0.46	0.81	0.47	0.19	0.37
Retained Earnings	-0.78	-0.58	-0.32	-0.48	-0.5	-0.58	-0.8	-0.43		-0.81	0.13	-0.73	-0.42	0.13	0.11	-0.32	-0.76	0.17	-0.83	-0.27	-0.86	0.0	-0.15	-0.81	-0.34	-0.6
Accounts Payable	0.98	0.92	0.48	0.77	0.78	0.94	0.98	0.54	-0.81		-0.01	0.94	0.21	-0.01	0.35	0.53	0.99	0.11	0.99	0.52	0.92	0.46	0.24	0.9	0.69	0.73
Cash	-0.03	0.03	-0.27	0.4	0.09	0.09	-0.03	-0.57	0.13	-0.01		0.05	0.32	1.0	-0.14	-0.13	-0.06	-0.2	0.0	0.0	0.02	0.08	-0.18	0.16	0.31	0.0
Non Current Assets Total	0.95	0.97	0.64	0.85	0.9	0.92	0.96	0.61	-0.73	0.94	0.05		0.28	0.05	0.45	0.7	0.95	0.29	0.95	0.69	0.81	0.53	0.39	0.92	0.68	0.7
Non Currrent Assets Other	0.16	0.14	0.19	0.26	0.29	0.02	0.19	0.07	-0.42	0.21	0.32	0.28		0.32	-0.24	0.23	0.18	-0.04	0.19	0.24	0.27	-0.16	0.22	0.38	0.0	0.1
Cash And Short Term Investments	-0.03	0.03	-0.27	0.4	0.09	0.09	-0.03	-0.57	0.13	-0.01	1.0	0.05	0.32		-0.14	-0.13	-0.06	-0.2	0.0	0.0	0.02	0.08	-0.18	0.16	0.31	0.0
Net Receivables	0.32	0.62	0.75	0.29	0.66	0.49	0.31	0.65	0.11	0.35	-0.14	0.45	-0.24	-0.14		0.78	0.41	0.84	0.28	0.8	0.19	0.88	0.66	0.27	0.54	0.41
Non Current Liabilities Total	0.51	0.75	0.95	0.43	0.85	0.53	0.54	0.84	-0.32	0.53	-0.13	0.7	0.23	-0.13	0.78		0.58	0.79	0.49	0.97	0.37	0.73	0.83	0.58	0.48	0.55
Inventory	0.98	0.94	0.53	0.78	0.81	0.95	0.98	0.58	-0.76	0.99	-0.06	0.95	0.18	-0.06	0.41	0.58		0.18	0.98	0.56	0.87	0.52	0.26	0.88	0.69	0.72
Other Current Assets	0.12	0.43	0.85	0.13	0.61	0.2	0.12	0.7	0.17	0.11	-0.2	0.29	-0.04	-0.2	0.84	0.79	0.18		0.06	0.8	-0.01	0.71	0.83	0.05	0.27	0.2
Other Stockholder Equity	0.99	0.9	0.44	0.8	0.76	0.94	0.99	0.49	-0.83	0.99	0.0	0.95	0.19	0.0	0.28	0.49	0.98	0.06		0.48	0.91	0.42	0.18	0.9	0.69	0.73
Total Liab	0.5	0.75	0.92	0.51	0.87	0.55	0.52	0.74	-0.27	0.52	0.0	0.69	0.24	0.0	0.8	0.97	0.56	0.8	0.48		0.38	0.81	0.8	0.56	0.6	0.61
Property Plant And Equipment Gross	0.87	0.76	0.36	0.64	0.66	0.79	0.87	0.43	-0.86	0.92	0.02	0.81	0.27	0.02	0.19	0.37	0.87	-0.01	0.91	0.38		0.31	0.22	0.85	0.63	0.66
Total Current Assets	0.46	0.69	0.64	0.5	0.68	0.63	0.45	0.46	0.0	0.46	0.08	0.53	-0.16	0.08	0.88	0.73	0.52	0.71	0.42	0.81	0.31		0.47	0.36	0.81	0.65
Short Term Debt	0.17	0.45	0.91	0.09	0.68	0.17	0.21	0.81	-0.15	0.24	-0.18	0.39	0.22	-0.18	0.66	0.83	0.26	0.83	0.18	0.8	0.22	0.47		0.31	0.12	0.16
Intangible Assets	0.86	0.84	0.48	0.73	0.76	0.81	0.88	0.47	-0.81	0.9	0.16	0.92	0.38	0.16	0.27	0.58	0.88	0.05	0.9	0.56	0.85	0.36	0.31		0.6	0.65
Common Stock Total Equity	0.69	0.74	0.35	0.75	0.64	0.8	0.67	0.19	-0.34	0.69	0.31	0.68	0.0	0.31	0.54	0.48	0.69	0.27	0.69	0.6	0.63	0.81	0.12	0.6		0.83
Common Stock	0.73	0.68	0.46	0.6	0.58	0.71	0.73	0.37	-0.6	0.73	0.0	0.7	0.1	0.0	0.41	0.55	0.72	0.2	0.73	0.61	0.66	0.65	0.16	0.65	0.83

Click cells to compare fundamentals

Orthofix Medical Account Relationship Matchups

Orthofix Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	18.9M	19.4M	19.7M	20.1M	36.7M	38.6M
Total Assets	495.6M	525.9M	476.6M	458.6M	925.3M	971.6M
Other Current Liab	64.7M	72.7M	70.3M	47.2M	93.8M	98.5M
Total Current Liabilities	84.9M	103.9M	105.8M	83.6M	165.2M	173.5M
Total Stockholder Equity	327.6M	356.9M	336.9M	336.9M	598.7M	628.7M
Property Plant And Equipment Net	62.7M	63.6M	59.3M	58.2M	159.1M	167.0M
Net Debt	(48.7M)	(71.4M)	(65.4M)	(30.8M)	96.4M	101.3M
Retained Earnings	57.7M	59.4M	21M	1.3M	(150.1M)	(142.6M)
Accounts Payable	19.9M	23.1M	26.5M	27.6M	58.4M	61.3M
Cash	69.7M	96.3M	87.8M	50.7M	37.8M	39.8M
Non Current Assets Total	235.1M	255.5M	207.1M	202.6M	504.9M	530.1M
Non Currrent Assets Other	11.9M	17.3M	16.7M	25.7M	33.4M	35.1M
Cash And Short Term Investments	69.7M	96.3M	87.8M	50.7M	37.8M	39.8M
Net Receivables	86.8M	72.4M	78.6M	82.9M	128.1M	79.5M
Liabilities And Stockholders Equity	495.6M	525.9M	476.6M	458.6M	925.3M	971.6M
Non Current Liabilities Total	83.1M	65.1M	33.9M	38.1M	161.4M	92.9M
Inventory	82.4M	84.6M	83.0M	100.2M	222.2M	233.3M
Other Current Assets	20.9M	17.0M	20.1M	22.3M	37.1M	21.1M
Other Stockholder Equity	271.0M	292.3M	314.0M	335.0M	746.5M	783.8M
Total Liab	168.0M	169.0M	139.7M	121.8M	326.6M	165.1M
Property Plant And Equipment Gross	62.7M	63.6M	242.2M	221.2M	347.7M	365.1M
Total Current Assets	260.6M	270.4M	269.5M	256.0M	420.4M	217.2M
Accumulated Other Comprehensive Income	3.3M	(3.0M)	3.3M	(1.4M)	(1.3M)	(1.2M)
Short Term Debt	323K	2.6M	4.4M	2.3M	5.4M	4.8M
Intangible Assets	54.1M	60.5M	52.7M	47.4M	117.5M	123.4M
Common Stock Total Equity	1.9M	1.9M	2.0M	2.0M	2.3M	1.9M
Common Stock	1.9M	1.9M	2.0M	2.0M	3.7M	2.0M
Other Liab	58.4M	39.8M	14.0M	13.5M	15.6M	16.4M
Other Assets	41.0M	47.3M	23.9M	12.8M	14.8M	28.8M
Good Will	72.4M	71.2M	84.0M	71.3M	194.9M	98.1M
Property Plant Equipment	62.7M	63.6M	59.3M	58.2M	67.0M	43.5M
Net Tangible Assets	202.3M	212.3M	213.0M	218.2M	250.9M	234.7M
Retained Earnings Total Equity	57.7M	59.4M	21M	1.3M	1.1M	1.1M
Capital Surpluse	271.0M	292.3M	314.0M	335.0M	385.2M	280.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Orthofix Stock Based Compensation vs Begin Period Cash Flow Analysis

Stock Based Compensation vs Begin Period Cash Flow

Stock Based Compensation vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Stock Based Compensation

Begin Period Cash Flow

Orthofix Medical fundamental ratios Correlations

Orthofix Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Orthofix Medical fundamental ratios Accounts

Also Currently Popular

Additional Tools for Orthofix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Common Stock Shares Outstanding
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Other Stockholder Equity	+ 0.99	Property Plant And Equipment Net
Inventory	+ 0.99	Accounts Payable
Other Stockholder Equity	+ 0.99	Accounts Payable

Property Plant And Equipment Gross	- 0.86	Retained Earnings
Other Stockholder Equity	- 0.83	Retained Earnings
Intangible Assets	- 0.81	Retained Earnings
Accounts Payable	- 0.81	Retained Earnings
Retained Earnings	- 0.8	Property Plant And Equipment Net
Retained Earnings	- 0.78	Common Stock Shares Outstanding